EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Management of Perianal Fistulizing Crohn’s Disease

Arshdeep Singh iD, Vandana Midha, Gursimran Singh Kochhar, Bo Shen, Ajit Sood iD

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad195 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Arshdeep Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Dayanand Medical College, Ludhiana, India. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 196 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perianal fistulizing Crohn’s disease (CD) represents a severe phenotype of CD that is associated with significant morbidity and reduction in quality of life. Perianal fistulizing CD is caused by a complex interplay of genetic predisposition, immune dysregulation, gut dysbiosis, and various unknown physiological and mechanical factors. A multidisciplinary approach is hence required for optimal management . A detailed anatomical description and classification of perianal fistula, including comprehensive clinical, endoscopic, and radiological diagnostic workup, is an important prerequisite to treatment. For simple perianal fistulas, use of antibiotics and immunomodulators, with or without fistulotomy, are appropriate measures. The medical management of complex perianal fistula, on the other hand, requires adequate control of infection before initiation of therapy with immunomodulators. In active complex perianal fistula, anti-tumor necrosis factors remain the most accepted therapy, with concomitant use of antibiotics or immunomodulators enhancing the efficacy. For patients refractory to anti-tumor necrosis factors, treatment with anti-integrins, anti-interleukins, and small molecules is being evaluated. Mesenchymal stem cells, hyperbaric oxygen therapy, and exclusive enteral nutrition have also been investigated as adjunct therapies. Despite the expansion of the medical armamentarium, a large proportion of the patients require surgical interventions. In this review, we provide an up-to-date overview of the pathophysiology, clinical presentation, diagnosis, and medical management of perianal fistulizing CD. A brief overview of the surgical management of perianal fistulizing CD is also provided.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRectal FistulaHumansDisease ManagementAnti-Bacterial AgentsQuality of Life

Stichwörter der Autor:innen

Crohn’s diseasebiologicsfistulizinginfliximabperianal diseaseperianal fistula

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Dayanand Medical College, Ludhiana, India.
  • Department of Internal Medicine, Dayanand Medical College, Ludhiana, India.
  • Division of Gastroenterology, Hepatology and Nutrition, Allegheny Health Network, Pittsburgh, PA, USA.
  • Center for Interventional Inflammatory Bowel Disease, NewYork-Presbyterian Hospital, Columbia University Irving Medical Center, New York, NY, USA.

ORCID-Profile: Arshdeep Singh, Ajit Sood

Zitieren

APA

Singh, A., Midha, V., Kochhar, G. S., Shen, B., & Sood, A. (2024). Management of Perianal Fistulizing Crohn’s Disease. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad195

Vancouver

Singh A, Midha V, Kochhar GS, Shen B, Sood A. Management of Perianal Fistulizing Crohn’s Disease. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad195

BibTeX
@article{Singh2024,
  author = {Singh, Arshdeep and Midha, Vandana and Kochhar, Gursimran Singh and Shen, Bo and Sood, Ajit},
  title = {Management of Perianal Fistulizing Crohn’s Disease},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad195}
}
Kostenlos starten →